newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO and REDWOOD CITY, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of